<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="75617">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01992744</url>
  </required_header>
  <id_info>
    <org_study_id>815839</org_study_id>
    <nct_id>NCT01992744</nct_id>
  </id_info>
  <brief_title>BDNF Pregnancy Study</brief_title>
  <acronym>BDNF</acronym>
  <official_title>Peripheral Serum BDNF Levels and Poor Birth Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the correlation between varying levels of
      neuropeptides and birth outcomes. Neuropeptides are substances (proteins) produced in the
      body in very small amounts but without which the nervous system cannot function properly,
      and which might have a role in the health of a newborn. As part of this study, we are
      collecting blood samples from pregnant women.

      Neuropeptides and hormones can be measured in blood. This study will involve three blood
      draws from the participants arm. Demographic information will also be requested, and
      participants will be asked to complete questionnaires about their mood and personal
      experiences at each visit.

      Our hypothesis is that participants with lower levels of brain-derived neurotrophic factor
      (BDNF) will be at increased risk for poor birth outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective, non-randomized trial will evaluate peripheral serum blood levels of BDNF
      in participants recruited from previously identified University of Pennsylvania obstetrics
      and gynecological (OB/GYN) clinics. A total of 100 pregnant subjects will be recruited
      consecutively and evaluated in the first and third trimester of their pregnancy as well as
      within a month after delivery.

      The entire project will take one year.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Anticipated">May 2015</completion_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Neuropeptide &amp; Blood Levels</measure>
    <time_frame>First Trimester (8 weeks to 12 weeks gestational age), Third Trimester (28 weeks to 32 weeks gestational age) &amp; Postpartum (30 days postpartum)</time_frame>
    <safety_issue>No</safety_issue>
    <description>BDNF
Complete blood count (CBC)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinician and Patient Ratings</measure>
    <time_frame>First Trimester (8 weeks to 12 weeks gestational age), Third Trimester (28 weeks to 32 weeks gestational age) &amp; Postpartum (30 days postpartum)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Edinburgh Postnatal Depression Score (EPDS)
Perceived Stress Scale Score (PSS)
Adverse Childhood Events Questionnaire Score (ACEs)
Beck Depression Inventory (BDI)
Brief Anxiety Inventory (BAI)
Brief Symptom Inventory (BSI)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Birth Outcomes</measure>
    <time_frame>Postpartum (30 days postpartum)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Birth weight (low birth weight &lt; 2.5 kg; very low birth weight &lt; 1.5 kg)
APGAR score (at one minute, at five minutes)
Preterm birth (before 37 weeks gestation; very early preterm birth, before 35  weeks gestation); gestational age at delivery
Infant mortality/ Neonatal Intensive Care Unit (NICU) Admission
Major congenital malformations (especially neurologic)
Head circumference (cm)</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>Healthy Pregnant Women</arm_group_label>
    <description>Participants 8 to 12 weeks gestational age as determined by their physician.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      - Brain-Derived Neurotrophic Factor
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women from the greater Philadelphia and surrounding areas who are ages 18 to 39 and
        between 8 to 12 weeks pregnant will be considered for enrollment into this study. All
        subjects must be physically healthy without a serious, major medical illness as well as be
        carrying a healthy fetus. Subject will be enrolled through OB/GYN waiting room recruiting,
        fliers, advertisements and social media outlets.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants must be at least 18 years old and being treated at an outpatient OB/GYN
             clinic;

          -  At least 8 weeks pregnant;

          -  Capable of giving informed consent.

        Exclusion Criteria:

          -  Participants younger than 18 years of age;

          -  History of preterm birth;

          -  Psychiatric medications during current pregnancy;

          -  Participants with a history of hematologic disorders;

          -  Participants who refuse informed consent.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Deborah R Kim, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant Professor University of Pennsylvania</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lisa C Lamprou, B.A.</last_name>
    <phone>(215) 573-8880</phone>
    <email>llamprou@mail.med.upenn.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Penn Center for Women's Behavioral Wellness</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa C Lamprou, B.A.</last_name>
      <phone>215-573-8880</phone>
      <email>llamprou@mail.med.upenn.edu</email>
    </contact>
    <contact_backup>
      <last_name>Kathryn Czarkowski, M.A.</last_name>
      <phone>(215) 573-8882</phone>
      <email>kczar@mail.med.upenn.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Deborah R Kim, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Penn Medicine Washington Square (PMWS)</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa C Lamprou, B.A.</last_name>
      <phone>(215) 573-8880</phone>
      <email>llamprou@mail.med.upenn.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jessica L Snell, PsyD Candidate</last_name>
      <phone>(215) 573-8877</phone>
      <email>jessnell@mail.med.upenn.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Deborah R Kim, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>3701 Market Street</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa C Lamprou, B.A.</last_name>
      <phone>215-573-8880</phone>
      <email>llamprou@mail.med.upenn.edu</email>
    </contact>
    <contact_backup>
      <last_name>Amy Weiss, B.A.</last_name>
      <phone>(215) 746-1158</phone>
      <email>weissamy@mail.med.upenn.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Deborah R Kim, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Helen O. Dickens Center for Women's Health, Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa C Lamprou, B.A.</last_name>
      <phone>(215) 573-8880</phone>
      <email>llamprou@mail.med.upenn.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jessica L Snell, PsyD Candidate</last_name>
      <phone>(215) 573-8877</phone>
      <email>jessnell@mail.med.upenn.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Deborah R Kim, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.med.upenn.edu/womenswellness/</url>
    <description>Program Website</description>
  </link>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>November 19, 2013</lastchanged_date>
  <firstreceived_date>October 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pregnancy</keyword>
  <keyword>brain-derived neurotrophic factor</keyword>
  <keyword>birth outcomes</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
